PHAT SCHEDULE 13G/A: SEC filing

Invesco Ltd.

Filed with the SEC on · accession 0000914208-26-000448

PHAT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.2% by the first close after the filing.

Summary of the filing

Invesco Ltd. filed an amended Schedule 13G indicating it beneficially owns 30,562 shares of Phathom Pharmaceuticals, representing 0.0% of the class, a passive investment position.

Key details

shares beneficially owned$31K
Filer / beneficial ownerInvesco Ltd.
IssuerPhathom Pharmaceuticals, Inc.
Global head of compliance, invesco ltd.Robert R. Leveille

How PHAT stock reacted

Close before

$5.33

Nov 9, 2026

First close after

+2.16%

$5.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PHAT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PHAT?

Click here

Frequently asked questions

What did PHAT file with the SEC on Nov 10, 2026?

PHAT filed a SCHEDULE 13G/A (SEC filing). Invesco Ltd. filed an amended Schedule 13G indicating it beneficially owns 30,562 shares of Phathom Pharmaceuticals, representing 0.0% of the class, a passive investment position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did PHAT stock react to this filing?

PHAT closed at $5.33 before the filing and $5.45 on Nov 10, 2026 (+2.16%).

Other PHAT SEC filings

Get alerts when PHAT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days